GlassScriptPhysician profile
Abhinav Saxena
NPI 1417397506
$6,620.40
in general payments reported to CMS, 2019-2025
34 companies · $1,318 in 2025
The $1,318 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,606 · 2021: $331 · 2022: $1,145 · 2023: $1,031 · 2024: $1,190 · 2025: $1,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,538.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,507.94 | 2020 | |
| Abiomed | $685.89 | 2022-2025 | Impella |
| Biotronik INC. | $634.14 | 2022-2025 | Orsiro Mission, Nhancer Rx, Amvia Edge |
| E.R. Squibb & Sons, L.L.C. | $361.80 | 2022-2025 | Camzyos, Cobenfy |
| Novartis Pharmaceuticals Corporation | $354.18 | 2022-2025 | |
| Abbott Laboratories | $302.82 | 2022-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Coronary |
| Shockwave Medical, INC | $238.29 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.43 | 2020-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $221.41 | 2021-2023 | Xarelto |
| Inari Medical, INC. | $182.67 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $181.99 | 2021-2025 | |
| Scpharmaceuticals INC. | $158.49 | 2024-2025 | |
| Amgen INC. | $145.48 | 2021-2024 | Repatha |
| Kestra Medical Technology Services, INC. | $136.56 | 2022-2025 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $135.56 | 2021-2025 | Uptravi, Opsumit |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $133.66 | 2023 | Glidesheath Slender |
| Merck Sharp & Dohme LLC | $111.16 | 2022-2025 | Verquvo, Winrevair |
| Boston Scientific Corporation | $110.82 | 2021-2025 | Farapulse, Ekosonic |
| Medtronic, INC. | $90.85 | 2022-2025 | Linq II, Symplicity G3 |
| Chiesi USA, INC. | $87.69 | 2024-2025 | Kengreal, Cleviprex |
| Sanofi-Aventis U.S. LLC | $78.78 | 2021-2024 | |
| Esperion Therapeutics, INC. | $77.16 | 2021-2025 | Nexletol |
| Amarin Pharma, INC. | $64.94 | 2021 | |
| Cardiovascular Systems INC. | $53.37 | 2022 | |
| Philips North America LLC | $51.98 | 2022-2024 | (Az7) Lasers |
| Biosense Webster, INC. | $51.82 | 2023-2024 | Carto 3 |
| Edwards Lifesciences Corporation | $41.93 | 2024 | |
| Atricure, INC. | $38.52 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.24 | 2023-2025 | Jardiance |
| W. L. Gore & Associates, INC. | $32.25 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Tactile Systems Technology INC | $23.86 | 2025 | Flexitouch Plus, Nimbl |
| Regeneron Healthcare Solutions, INC. | $21.12 | 2023 | Praluent, Evkeeza |
| Kowa Pharmaceuticals America, INC. | $16.70 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhinav Saxena listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.